Recombinant factor VIIa for the management of severe hemorrhages in patients with hematologic malignancies

MeSH terms

• Adult
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• Child
• Drug Evaluation
• Factor VIIa / therapeutic use*
• Female
• Graft vs Host Disease / complications
• Hematologic Neoplasms / complications*
• Hematologic Neoplasms / drug therapy
• Hematologic Neoplasms / therapy
• Hematopoietic Stem Cell Transplantation
• Hemorrhage / drug therapy*
• Hemorrhage / etiology
• Hemorrhage / therapy
• Humans
• Male
• Middle Aged
• Platelet Transfusion
• Recombinant Proteins / therapeutic use
• Treatment Outcome